Table 5 TEAEs reporting in each treatment group during the initial 8-week treatment Period 1
Placebo N = 12 | Minocyclin 8 week N = 22 | |
|---|---|---|
TEAEs – n° (%) patients | 1 (8.3) | 4 (18.8) |
Number of TEAEs | 1 | 4 |
Infection | 1 | |
Constipation | ||
Diarrhea | 1 | |
Cutaneous alterations | 1 | |
Coloration dental | ||
Nauseas | 1 | |
Edemas | ||
Increase urine concentration | 1 | |
Serious adverse events – n° of patients (%) | 0 | 0 |
TEAEs leading to treatment discontinuation N (%) patients | 0 | 1 (4.5)a |